Pacific Biosciences of California, Inc. (PACB)
2.355
+0.14
(+6.56%)
USD |
NASDAQ |
Jan 20, 16:00
2.34
-0.02
(-0.64%)
After-Hours: 17:06
Pacific Biosciences of California Profit Margin (Quarterly): -98.85% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp. | 14.91% |
| Intellia Therapeutics, Inc. | -735.2% |
| Twist Bioscience Corp. | -27.41% |
| Beam Therapeutics, Inc. | -1.16K% |
| Bruker Corp. | -6.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -218.7% |
| Return on Assets | -48.31% |
| Return on Invested Capital | -51.88% |
| Gross Profit Margin (Quarterly) | 39.20% |
| Operating Margin (Quarterly) | -101.0% |
| Return on Net Operating Assets | -77.28% |